Cancer-associated fibroblasts actively compress cancer cells and modulate mechanotransduction

dc.contributor.authorBarbazán, Jorge
dc.contributor.authorPérez González, Carlos
dc.contributor.authorGómez González, Manuel
dc.contributor.authorDedenon, Mathieu
dc.contributor.authorRichon, Sophie
dc.contributor.authorLatorre, Ernest
dc.contributor.authorSerra, Marco
dc.contributor.authorMariani, Pascale
dc.contributor.authorDescroix, Stéphanie
dc.contributor.authorSens, Pierre
dc.contributor.authorTrepat Guixer, Xavier
dc.contributor.authorMatic Vignjevic, Danijela
dc.date.accessioned2026-02-26T09:17:49Z
dc.date.available2026-02-26T09:17:49Z
dc.date.issued2023-11-01
dc.date.updated2026-02-26T09:17:49Z
dc.description.abstractDuring tumor progression, cancer-associated fibroblasts (CAFs) accumulate in tumors and produce an excessive extracellular matrix (ECM), forming a capsule that enwraps cancer cells. This capsule acts as a barrier that restricts tumor growth leading to the buildup of intratumoral pressure. Combining genetic and physical manipulations in vivo with microfabrication and force measurements in vitro, we found that the CAFs capsule is not a passive barrier but instead actively compresses cancer cells using actomyosin contractility. Abrogation of CAFs contractility in vivo leads to the dissipation of compressive forces and impairment of capsule formation. By mapping CAF force patterns in 3D, we show that compression is a CAF-intrinsic property independent of cancer cell growth. Supracellular coordination of CAFs is achieved through fibronectin cables that serve as scaffolds allowing force transmission. Cancer cells mechanosense CAF compression, resulting in an altered localization of the transcriptional regulator YAP and a decrease in proliferation. Our study unveils that the contractile capsule actively compresses cancer cells, modulates their mechanical signaling, and reorganizes tumor morphology.
dc.format.extent17 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec766700
dc.identifier.issn2041-1723
dc.identifier.urihttps://hdl.handle.net/2445/227494
dc.language.isoeng
dc.publisherNature Publishing Group
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41467-023-42382-4
dc.relation.ispartofNature Communications, 2023, vol. 14, num.1, p. 1-17
dc.relation.urihttps://doi.org/10.1038/s41467-023-42382-4
dc.rightscc-by (c) Barbazan, Jorge et al., 2023
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Institut de Bioenginyeria de Catalunya (IBEC))
dc.subject.classificationCàncer
dc.subject.classificationFibroblasts
dc.subject.classificationTumors
dc.subject.otherCancer
dc.subject.otherFibroblasts
dc.subject.otherTumors
dc.titleCancer-associated fibroblasts actively compress cancer cells and modulate mechanotransduction
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
922391.pdf
Mida:
5.96 MB
Format:
Adobe Portable Document Format